Kestra Medical (KMTS) CEO Brian Webster Sells 15,000 Shares

What Happened Brian Webster, President and Chief Executive Officer of Kestra Medical Technologies, Ltd. (KMTS), sold 15,000 shares on 2026-08-17 in an open-market/privately arranged sale. The reported weighted-average sale price was $27.48 per share for total proceeds of $412,181. The actual sale prices ranged from $26.92 to $27.77. The filing indicates the trades were made pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

Key Details

• Transaction date: 2026-08-17; Form 4 filed: 2026-08-18 (timely).
• Shares sold: 15,000; weighted-average price: $27.48; proceeds: $412,181.
• Price range reported: $26.92 – $27.77. The filer can provide the breakdown by price on request (per footnote).
• Shares owned after transaction: not disclosed in the provided filing.
• Footnotes: F1 — sale executed under a Rule 10b5-1 plan (adopted 9/29/2025). F2 — weighted-average price and range disclosed.
• Transaction code: S = Sale.

Context This was a sale, not a purchase or option exercise. Trades under Rule 10b5-1 plans are pre-set and typically follow a pre-arranged schedule; they are often routine and do not by themselves indicate a change in insider sentiment. Retail investors should note sales are common for liquidity or diversification reasons; purchases generally carry more weight when assessing insider conviction.